Consensus document of the Spanish Society of Liver Transplantation. Waiting lists, liver transplantation and quality indicators;Documento de consenso de la Sociedad Española de Trasplante Hepático. Lista de espera, trasplante pediátrico e indicadores de calidad

Gastroenterologia y Hepatologia

Volumn 32, Issue 10, 2009, Pages 702-716

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASCITES; BILE DUCT CARCINOMA; BUDD CHIARI SYNDROME; CHOLANGITIS; CLASSIFICATION; CONSENSUS; FAMILIAL AMYLOID POLYNEUROPATHY; HEALTH CARE QUALITY; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; HYPEROXALURIA; LIVER CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PATIENT SATISFACTION; PERIOPERATIVE PERIOD; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; QUALITY CONTROL; REGISTRATION; TREATMENT INDICATION;

ADULT; CHILD; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUALITY INDICATORS, HEALTH CARE; REOPERATION; SEVERITY OF ILLNESS INDEX; SPAIN; WAITING LISTS;

EID: 71549162843     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2009.06.007     Document Type: Article

References (38)

1. Sociedad Española de Trasplante Hepático. Gastroenterol Hepatol. 2008;31:82-91.
2. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
3. Forman L., and Lucey M. Predicting the prognosis of chronic liver disease: An evolution from child to MELD. Hepatology 33 (2001) 473-475
4. Said A., Williams J., Holden J., Remington P., Gangnon R., Musat A., et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 40 (2004) 897-903
5. Cárdenas A., and Gines P. Predicting mortality in cirrhosis-serum sodium. N Engl J Med 359 (2008) 1060-1062
6. Kim W.R., Biggins S.W., Kremers W.K., Wiesner R.H., Kamath P.S., Benson J.T., et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359 (2008) 1018-1026
7. Merion R.M., Schaubel D.E., Dykstra D.M., Freeman R., Port F.K., and Wolfe R.A. The survival benefit of liver transplantation. Am J Transplant 5 (2005) 307-313
8. Lucey M.R., Schaubel D.E., Guidinger M.K., Tome S., and Merion R.M. A disease specific analysis of the effect of alcoholic liver disease and hepatitis C infection on waiting list mortality, post-transplant mortality and transplant survival benefit. Am J Transplant 8 (2008) 196
9. Poynard T., Barthelemy P., Fratte S., Boudjema K., Doffoel M., Vanemmens C., et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 344 (1994) 502-507
10. Poynard T., Naveau S., Doffoel M., Boudjema K., Vanlemmens C., Mantion G., et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group. J Hepatol 30 (1999) 1130-1137
11. Trotter J.F., and Osgood M.J. MELD scores of liver transplant recipients according to size of waiting list: Impact of organ allocation and patient outcomes. JAMA 291 (2004) 1871-1874
12. Freeman R.B., Gish R.G., Harper A., Davis G.L., Vierling J., Lieblein L., et al. Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 12 (2006) S128-S136
13. Forner A., Ayuso C., Isabel Real M., Sastre J., Robles R., Sangro B., et al. Diagnosis and treatment of hepatocellular carcinoma. Med Clin (Barc) 132 (2009) 272-287
14. Alessandria C., Ozdogan O., Guevara M., Restuccia T., Jiménez W., Arroyo V., et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. Hepatology 41 (2005) 1282-1289
15. Fallon M.B., Mulligan D.C., Gish R.G., and Krowka M.J. Model for End-Stage Liver Disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl 12 (2006) S105-S107
16. Krowka M.J., Fallon M.B., Mulligan D.C., and Gish R.G. Model for End-Stage Liver Disease (MELD) exception for portopulmonary hypertension. Liver Transpl 12 (2006) S114-S116
17. Ramsay M.A. Perioperative mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 6 (2000) 451-452
18. Gores G.J., Gish R.G., Shrestha R., and Wiesner R.H. Model for End-Stage Liver Disease (MELD) exception for bacterial cholangitis. Liver Transpl 12 (2006) S91-S92
19. Horslen S., Gish R.G., and McDonald R. Model for End-Stage Liver Disease (MELD) exception for primary hyperoxaluria. Liver Transpl 12 (2006) S117-S118
20. Horslen S., Sweet S., Gish R.G., and Shepherd R. Model for End-Stage Liver Disease (MELD) exception for cystic fibrosis. Liver Transpl 12 (2006) S98-S99
21. Punch J., and Gish R.G. Model for End-Stage Liver Disease (MELD) exception for uncommon hepatic tumors. Liver Transpl 12 (2006) S122-S123
22. Pomfret E., Gish R.G., and Brandhagen D. Model for End-Stage Liver Disease (MELD) exception for familial amyloidotic polyneuropathy. Liver Transpl 12 (2006) S100-S101
23. Sheiner P., Belghiti J., Gish R.G., and Miller C. Model for End-Stage Liver Disease (MELD) exception for small-for-size syndrome. Liver Transpl 12 (2006) S120-S121
24. Arrazola L., Moonka D., Gish R.G., and Everson G.T. Model for End-Stage Liver Disease (MELD) exception for polycystic liver disease. Liver Transpl 12 (2006) S110-S111
25. Gores G.J., Gish R.G., Sudan D., and Rosen C.B. Model for End-Stage Liver Disease (MELD) exception for cholangocarcinoma or biliary dyspepsia. Liver Transpl 12 (2006) S95-S97
26. Washburn W.K., Gish R.G., and Kamath P.S. Model for End-Stage Liver Disease (MELD) exception for Budd-Chiari syndrome. Liver Transpl 12 (2006) S93-S94
27. Ham J., Gish R.G., and Mullen K. Model for End-Stage Liver Disease (MELD) exception for hepatic encephalopathy. Liver Transpl 12 (2006) S102-S104
28. Sheiner P., Gish R.G., and Sanyal A. Model for End-Stage Liver Disease (MELD) exception for portal hypertensive GI bleeding. Liver Transpl 12 (2006) S112-S113
29. Washburn W.K., and Gish R.G. Model for End-Stage Liver Disease (MELD) exception for severe pruritis. Liver Transpl 12 (2006) S119
30. Rosen H.R., Prieto M., Casanovas-Taltavull T., Cuervas-Mons V., Guckelberger O., Muiesan P., et al. Validation and refinement of survival models for liver retransplantation. Hepatology 38 (2003) 460-469
31. Eason J.D., Gonwa T.A., Davis C.L., Sung R.S., Gerber D., and Bloom R.D. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 8 (2008) 2243-2251
32. Schaubel D.E., Sima C.S., Goodrich N.P., Feng S., and Merion R.M. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 8 (2008) 419-425
33. McDiarmid S.V., Merion R.M., Dykstra D.M., and Harper A.M. Use of a pediatric end-stage liver disease score for deceased donor allocation: The United States experience. Indian J Pediatr 74 (2007) 387-392
34. Bourdeaux C., Thanh Tri T., Gras J., Sokal E., Otte J.B., De Ville de Goyet J., et al. PELD Score and posttransplant outcome in pediatric liver transplantation: A retrospective study of 100 recipients. Transplantation 79 (2005) 1273-1276
35. McDiarmid S.V., Anand R., Lindblad A.S., and the Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74 (2002) 173-181
36. Mazariegos G.V., Anand R., and McDiarmid S.V. Validation of PELD Severity Score in a Pediatric Transplant Candidate Database. Am J Trans 2 (2002) 251
37. McDiarmid S.V., Goodrich N.P., Harper A.M., and Merion R.M. Liver transplantation for Status 1: The consequences of good intentions. Liver Transpl 13 (2007) 699-707
38. Broering D.C., Sterneck M., and Rogiers X. Living donor liver transplantation. J Hepatol 38 (2003) S119-S135